There's been an alarming increase of respiratory and gastrointestinal viruses in the United States lately, causing anxiety about a so-called "quad-demic". According to surveillance reports, influenza, COVID-19, RSV and norovirus are at very high levels everywhere. While the surge aligns with patterns typical for this season, several epidemiologists view simultaneous infections of such proportions to pose risks not only to individual healthcare but public health.

The incidence of the quad-demic should vary with seasonal patterns, vaccination rates, and public health interventions. Each virus alone is relatively easy to manage; however, the effect of all together could lead to overburdening of health care facilities and increase risks for those at higher risk. Continuing surveillance, early testing, and proactive prevention measures will play an important role in the control of these infections going forward.

While the term "quad-demic" sounds daunting, it must be taken into perspective. For years, we have had all these viruses together, and we have the capabilities to mitigate some of the risk. Vaccination, proper hygiene and using common sense helps individuals get through the season unscathed. Is the quad-demic a permanent fixture or just another seasonal wave? Let's break this down.

What is the Quad-demic?

Typically, flu, COVID-19, and RSV have been the primary culprits behind seasonal respiratory infections. However, norovirus, a highly contagious stomach bug, has emerged as a fourth significant player, inducing fears of a more severe and widespread viral outbreak. According to the Centers for Disease Control and Prevention (CDC), the U.S. recorded nearly 500 norovirus outbreaks between August and December 2023, a substantial rise from the previous year’s numbers.

While the term "quad-demic" may sound ominous, the seriousness and consequences of such infections should be weighed in light of the U.S. healthcare system's experience with managing viral surges since the start of the COVID-19 pandemic.

1. Influenza (Flu)

Flu continues to be one of the most common and alarming seasonal illnesses. In the period spanning from 2023 to 2024, there were approximately 40 million cases of flu, and thousands of hospitalizations along with reported 47 deaths have been reported this season. Flu symptoms include fever, chills, cough, sore throat, muscle pain, and fatigue, with most recovering within a week or two but risky factors for severe illness effects occur in young children, elderly, and people with chronic conditions.

2. Covid-19

Despite its reduction from the first pandemic peak, COVID-19 is still rampant. The CDC estimates that alone between October and December 2023, there were between 2.7 and 5 million cases in the U.S. Hospitalization has increased by cities such as Los Angeles, Chicago, and New York. Symptoms are closely similar to the flu, fever, cough, and fatigue but uniquely presents in some cases as loss of taste and smell.

3. RSV

RSV is the most common cause of lower respiratory infections in infants, older adults, and immunocompromised individuals. While RSV peaked late in 2023 and early 2024, it continues to be a threat because it can lead to bronchiolitis and pneumonia. It is very similar to the common cold, presenting with symptoms such as congestion, runny nose, coughing, and fever, which can make it difficult to differentiate from flu or COVID-19 without testing.

4. Norovirus

Norovirus, also called the "stomach flu," is a highly contagious infection of the gastrointestinal tract, not a respiratory virus. It transmits quickly from contaminated food and water and contact with contaminated surfaces, causing such symptoms as diarrhea, vomiting, nausea, and stomach pain. Cases have shot up, the CDC said Monday, with reports of outbreaks surging compared with last year.

Is There a Challenge In Diagnosis Due to Overlapping Symptoms?

The greatest challenge during the quad-demic is how the four viruses are alike and thus make identification very hard with no testing applied. Most cases present symptoms common to all viruses: fever, tiredness, body pains, and respiratory, which includes coughing and congestions for influenza, COVID-19, and RSV; the other would be norovirus symptoms as nausea and vomiting can appear even in extreme influenza and COVID-19. This overlap increases the risk of misdiagnosis and delayed treatment, hence the need for early testing and proper medical guidance.

Also Read: Is US Preparing For A Quad- demic 2025?

Effective Prevention Strategies That Work

The best defense against these viruses is a combination of vaccines, hygiene, and lifestyle precautions. While lifestyle modifications are highlighted as part of the constant need to eat healthy, ensure daily movement and drinking adequate amount of fluids. There is a sure short two preventive strategies that are effective:

Vaccination

• Flu vaccine: Annual flu shots reduce the severity of infection, allergic flare ups and hospitalizations.
• COVID-19 vaccine: Though COVID-19 cases have declined, vaccination remains critical in preventing severe outcomes.
• RSV vaccine: Available for those aged 60 years and older, especially those with underlying conditions.
• Norovirus vaccine: No vaccine is yet available, but mRNA vaccine research is in progress.

Hygiene and Sanitation

• Washing hands frequently with soap and water for at least 20 seconds, especially after public exposure.
• Disinfect frequently touched surfaces regularly, use sanitiser when outside.
• Avoid close contact with infected people and wear masks.

Do You Need To Wear A Mask All The Time?

While debates on masked wear continue on, experts on mask-wear affirm that this does not only have a historical precedent but works towards reducing airborne viruses spreading within the environments. Hospitals, though, ensure masking in key sections of themselves. Publicized mask-wear remains a discretion, though massing indoors still goes a longer way in cases like peak flu seasons.

If you notice the symptoms of these viruses, then it's best to be confined at home and avoid having face-to-face interaction with others and seek immediate attention from your physician if your condition worsens. Quarantining for some days can decrease the spread of infection.

As we move into the first half of 2025 and beyond, staying informed and proactive is the best strategy for maintaining health and avoiding unnecessary panic. The key takeaway? Stay vigilant, but don’t be alarmed—these viruses are here, but so are the means to fight them.

Amid a global increase in multidrug resistance, the World Health Organization (WHO) has released new guidelines that flags the lack of innovative antibiotics for vulnerable populations, as well as press the need for the rapid development of drugs to target three deadly bacterial infections.

The WHO's 2025 report on antibacterials in pipeline has highlighted that 90 new antibacterial agents are in preclinical or clinical development. Yet few are innovative antibiotic candidates with potential to target bacterial priority pathogens.

The WHO-developed Target Product Profiles (TPPs) call for accelerating the development of antibiotics to tackle the burden of drug-resistant bacteria in at-risk populations worldwide that lead to:

• Severe multidrug-resistant gram-negative infections such as bloodstream infections and hospital-acquired or ventilator-associated bacterial pneumonia. These are caused by carbapenem-resistant Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa.

• Severe antibiotic-resistant gram-positive infections in immune-suppressed and critically ill patients. It is caused by Enterococcus faecium
• Community-acquired and health care-associated bacterial meningitis -- a devastating and deadly disease that not only accelerates fatality rate but also causes long-term disabilities, including hearing loss, epilepsy or cognitive impairment.

“The scientific community has developed and approved new antibiotics in recent years. This is good, but unfortunately not sufficient to catch up with evolving drug-resistant bacteria, especially against those of greatest concern,” said Dr Yvan Hutin, Director of Antimicrobial Resistance at WHO.

"We need a reliable pipeline with new antibacterial agents that are innovative, affordable, and accessible to all those who need them.”

The TPPs have been developed with extensive global consultation and also define the minimum and preferred characteristics of future antibacterials against these diseases, which specifically increase the risk of immunosuppressed people and critically ill patients. The vulnerable populations are also at risk of more deaths, prolonged hospitalizations and increased demand for intensive care that in turn strains health care systems.

What The TPPs Seek

The TPPs share a blueprint which:

• prioritizes developing antibiotics for infections with high morbidity and mortality
• sets specific standards for quality, efficacy, safety, and pharmacokinetics
• includes diverse and vulnerable populations, including immunosuppressed patients, critically ill patients, neonates, and children
• promotes partnerships between public and private sector

Rising Global Antimicrobial Resistance

Antimicrobial resistance (AMR) occurs when germs develop the ability to defeat the drugs designed to kill them.

It is one of the 10 top global health threats, undermining the effectiveness of essential treatments and placing millions at risk of untreatable infections.

As per WHO data, AMR is an urgent global public health threat, killing at least 1.27 million people worldwide and associated with nearly 5 million deaths in 2019.

In the US alone, more than 2.8 million antimicrobial-resistant infections occur each year. More than 35,000 people die as a result, according to CDC's 2019 Antibiotic Resistance (AR) Threats Report.

The WHO in a 2025 report noted that one in six laboratory-confirmed bacterial infections causing common infections in people worldwide in 2023 were resistant to antibiotic treatments.

Between 2018 and 2023, antibiotic resistance rose in over 40 percent of the monitored antibiotics with an average annual increase of 5-15 percent.

About 13 people, including a 3-year-old child, have died in East Godavari district of Andhra Pradesh in recent days, allegedly after consuming adulterated milk.

Dozens more are hospitalized and receiving treatment at hospitals in Rajamahendravaram, according to PTI news agency.

The cases first came to light on February 22, when several elderly residents were admitted to hospitals with symptoms such as anuria (absence of urine production), vomiting, abdominal pain, and kidney failure, requiring dialysis.

"The death toll in the suspected milk adulteration case in East Godavari district has reached 13, while seven persons are undergoing treatment at hospitals in Rajamahendravaram," health officials said.

Action Taken

Primary investigations indicated milk adulteration as the major reason behind the cases. High blood urea and serum creatinine levels in medical examinations of the victims also suggested possible toxic exposure.

The contaminated milk was reportedly supplied to nearly 106 families by Varalakshmi Milk Dairy in Narasapuram village of Korukonda mandal. Following the cases, the supply was immediately halted, the report said.

To curb further fatalities and hospitalization, officials have set up emergency medical camps in affected localities, with doctors and ambulances deployed round the clock.

The suspected milk vendor, Addala Ganeswararao (33), a resident of Narasapuram village, has also been taken into custody, and the associated dairy unit has been sealed.

The state Food Safety Department also plans to distribute pamphlets and booklets in educational institutions to raise awareness about identifying adulterated milk.

Recent Cases Of Contaminated Food In India

Earlier this month, the Uttar Pradesh Food Safety and Drug Administration (UPFSDA) issued 37 notices for non-compliance to sellers of substandard oil. The department also seized oil worth Rs. 6.43 crore.

Additionally, the FSSAI seized fake paneer near Noida, 1,400 kg of fake khoya in Jhansi, and 400 kg of expired ghee.

Health and Me had previously reported on FSSAI raids in Kanpur, where adulterated oil, rotten dates, and sweets were found. Bacteria were found in Amul milk packages, along with Mother Dairy and Country Delight.

Also read: FSSAI Reveals Key Tips To Keep Your Kitchen Healthy – How To Spot High Quality Vegetables?

FSSAI In Action

In February, the FSSAI launches a nationwide adulteration drive to curb adulteration in sweets, milk products, edible oils, and other festive foods.

The food regulator also led intensive inspections and on-the-spot testing through Food Safety on Wheels across States/UT.

Fisheries, Animal Husbandry, and Dairying Minister Rajiv Ranjan Singh today informed the Lok Sabha about action taken by FSSAI against the violators during 2025-26.

"A total of 1,65,747 samples were analyzed by the FSSAI between 2025-26. Of these, 28,450 were found non-conforming, with 6492 unsafe and 19,073 in the sub-standard category," Singh told the Parliament.

During the period, a total of 2,493 samples were analyzed in Andhra Pradesh. Of these, 216 were found non-conforming, with 101 in the 'unsafe' and 114 'sub-standard' category.

On March 9, the United States issues a travel advisory against global polio and listed 32 countries, including some European countries. The International travel often comes with vaccine reminder and health checks to stay safe. The Centers for Disease Control and Prevention (CDC) issued a Level 2 travel advisory for certain international destinations with circulating poliovirus. The CDC has asked travelers to ensure they are up to date on their polio vaccines.

Also Read: Harish Rana Case Brings Spotlight On How Passive Euthanasia Has Evolved Over The Years

The Destination list for global polio travel Advisory notice includes:

• Afghanistan
• Algeria
• Angola
• Benin
• Burkina Faso
• Cameroon
• Central African Republic
• Chad
• Côte d'Ivoire
• Democratic Republic of the Congo
• Djibouti
• Ethiopia
• Gaza
• Germany
• Guinea
• Israel
• Laos
• Namibia
• Niger
• Nigeria
• Pakistan
• Papua New Guinea
• Poland
• Senegal
• Somalia
• South Sudan
• Sudan
• Tanzania
• United Kingdom
• Yemen

The CDC issued a 'Level 2' advisory, which means to 'practice enhanced precautions'.

The advisory suggests that children and adults should be up to date on their routine polio vaccines. Travelers are also asked to get an inactivated polio vaccine booster if they are going to the destination that has circulating poliovirus, or have completed their routine polio vaccine series; and have not already received one adult booster dose.

Also Read: Colon Cancer Is The Leading Cause Of Death In US For People Under 50

If Polio Has Been Eliminated In The US, Then Why Do Travelers Need Advisory?

Dr Leana Wen, CNN wellness expert, who is an emergency physician and adjunct associate professor at the George Washington University said that while the US eliminated continuous transmission of polio in 1979, eradication within the country does not eliminate the risk when people travel to places where the virus is still circulating.

Speaking to CNN, Wen said that the risk for any individual traveler is usually low if they are fully vaccinated, however, from a population health perspective, it is important to take the precautionary steps. "Even a single imported case could lead to local spread in communities where vaccination coverage is low."

Types Of Notices Issued By CDC

The CDC issues four different types of notices based on the gravity of the disease spread.

Level 1 : Practice Usual Precautions

Practice usual precautions for this destination, as described in the Travel Health Notice and/or on the destination page.

Level 2: Practice Enhanced Precautions

Practice enhanced precautions for this destination. The Travel Health Notice describes additional precautions or defines a specific population at risk.

Level 3: Reconsider Nonessential Travel

Reconsider nonessential travel to this destination. The outbreak or event poses risk to travelers because limited precautions are available.

Level 4: Avoid All Travel

Avoid travel to this destination unless traveling for humanitarian aid or emergency response; there is an extreme health risk for travelers and no available precautions.

What Is Polio?

The World Health Organization (WHO) notes that it is a highly infectious disease caused by a virus that invades the nervous system and can cause total paralysis in matter of hours. The virus is transmitted by person to person spread mainly through the fecal-oral route, or less frequently, by a common vehicle, which could be either from contaminated food or water. The virus also multiplies in the intestine.

The National Institute of Health (NIH), US, notes that the virus responsible for causing Polio belongs to the Picornaviridae family.

As per the WHO, the common Polio symptoms are:

• Fever
• Fatigue
• Headache
• Vomiting
• Stiffness of the neck a
• Pain in the limbs

How Does Polio Spread?

Polio is mainly transmitted through the fecal-oral route, meaning it spreads when a person consumes food or water contaminated with the virus. It can also spread through close contact with an infected individual. The poliovirus lives in the throat and intestines of those infected, and poor sanitation, unsafe water, and inadequate hygiene greatly increase the risk of transmission, especially in communities with limited access to clean facilities.

In severe cases, polio can lead to acute flaccid paralysis, which may affect the diaphragm and throat muscles, making it difficult to breathe or swallow. Since there is no cure for polio, prevention remains the only line of defense. Raising awareness about polio vaccination is therefore essential to protect individuals, especially children, from this potentially life-threatening disease.